ESMO 2014 Report: Proton beam therapy: Emperor’s new clothes
by Denis Wheatley: In her introduction, Yolane Lievens (Belgium) explained that when we have to defer from making comment because of the need to be discrete (the Emperor… read more.
by Denis Wheatley: In her introduction, Yolane Lievens (Belgium) explained that when we have to defer from making comment because of the need to be discrete (the Emperor… read more.
Keynote lecture: Professor Sir Mike Stratton (Cambridge/Hinxton, UK) by Denys Wheatley. On the thesis that the genetic understanding of cancer is fundamental to classifying and hence treating patients… read more.
Click ‘Read More’ for the new data delegate views on whether early tumour shrinkage is now an accepted marker in mCRC.
by Denys Wheatley: Chaired by Atsushi Ohtsu and Jean-Yves Douillard, the first speaker Dr Kato (Japan) addressed the issue of the quest for different mutations in the hope… read more.
by Denys Wheatley: A large cohort study of Regorafenib (REG) in the real-life setting in patients previously treated for metastatic colorectal cancer
by Denys Wheatley: The session dealt primarily with the advanced (stage 2 and 3) colon cancer patients who had undergone resection, in a study discussed by Thiery Andre… read more.
by Bruce Sylvester: Ten-year follow-up of children with familial hypercholesterolemia treated with a statin showed an association between statin treatment and normalization of carotid intima-media thickness (IMT), a… read more.
Reports from the European Society for Medical Oncology 2014 Congress in Madrid by Denys Wheatley: In his talk on Visualising the true spectrum of cancer- will we get… read more.
by Bruce Sylvester – Microvascular complications of diabetes that can lead to blindness and amputations might be reduced by statin therapy, researchers reported on Sept.9, 2014 in The… read more.
Advertisment